As more and more people, including well-known athletes like tennis champion Serena Williams, use popular GLP-1 drugs like Wegovy and Mounjaro (her medication of choice), to lose weight and get back in shape, this question is being asked more frequently
Mxico (3) Department of Oral Pathology, Dental School, University of Campinas, Piracicaba-UNICAMP
Novo Nordisk, the manufacturer of Wegovy, has acknowledged the supply constraints and indicated that patients may continue to face difficulties in obtaining the medication, particularly the lower doses (0.25 mg, 0.5 mg, 1 mg) through September 2024
service members should avoid non-FDA-approved peptides, including Kisspeptin
The review focuses explicitly on Glucagon-Like Peptide-1 (GLP-1) receptor agonists, newer multi-receptor agonists, and emerging oral small-molecule therapies